Log in to save to my catalogue

Current treatment of IgA nephropathy

Current treatment of IgA nephropathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8551131

Current treatment of IgA nephropathy

About this item

Full title

Current treatment of IgA nephropathy

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Seminars in immunopathology, 2021-10, Vol.43 (5), p.717-728

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and GFR loss, if any, is slow. The mainstay of therapy therefore is optimized supportive care, i.e., measures that lower blood pressure, reduce proteinuria, minimize lifestyle ri...

Alternative Titles

Full title

Current treatment of IgA nephropathy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8551131

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8551131

Other Identifiers

ISSN

1863-2297

E-ISSN

1863-2300

DOI

10.1007/s00281-021-00888-3

How to access this item